Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

United Therapeutics Corp. (UTHR)

NASDAQ

$500.34

$-2.42

(-0.48%)

Pre-Market

United Therapeutics Corp. (UTHR) Live Price Chart

Last updated: ⁦2026-09-16 10:32:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

United Therapeutics Corp. (UTHR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $500.34, with a market capitalisation of $21.56B and a P/E ratio of 16.37. Over the past 52 weeks, its price has ranged from $397.00 to $609.35. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$21.56B
Open	$505.44
Day's High	$609.35
Day's Low	$18.22
Previous Close	$502.70
Volume	324.26K
Average Volume	545.76K
P/E Ratio	16.37
52-Week High	$609.35
52-Week Low	$397.00
Dividend Yield	--
Earnings Date	--

United Therapeutics Corp. (UTHR) Pre-Market Stock Price

United Therapeutics Corp. (UTHR) is trading at $502.76 in pre-market trading as of 2026-09-15 23:48:00, up 0.01% ($0.06) from the previous close of $502.70

Pre-market trading shows how investors are pricing UTHR before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

United Therapeutics Corp. (UTHR) 7-Day Stock Price Change

Over the past seven days, United Therapeutics Corp. (UTHR) moved from $487.61 to $500.34, representing a gain of 2.61% ($12.73).

The stock traded between $479.71 and $509.79 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 701.08 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

UTHR 52-Week Price Position

Position in Range: 48.7%

52W Low$397.00

52W High$609.35

UTHR is currently trading at $500.34, placing it 48.7% of the way from its 52-week low of $397.00 to its 52-week high of $609.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is United Therapeutics Corp. (UTHR)?

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

United Therapeutics Corp. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1400
Exchange	NASDAQ
Company Website	https://www.unither.com

How to Buy United Therapeutics Corp. (UTHR) Stock on MEXC

Eligible investors can buy real shares of United Therapeutics Corp. (UTHR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for UTHR and Place Your Order

Open the RealStocks trading page and search for UTHR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is United Therapeutics Corp. (UTHR) stock price today?

United Therapeutics Corp. (UTHR) is currently trading at $ 500.34, down 0.47% ($2.36) from the previous close of $ 502.70. Intraday prices update in real time during regular trading hours.

2.Is UTHR stock going up or down today?

As of 2026-09-15 23:48:00, UTHR is trading at $ 500.34, down 0.47% ($2.36) from its previous close of $ 502.70. The stock has traded between $ 18.22 and $ 609.35 during today’s regular session. Past price movements do not guarantee future results.

3.What is UTHR pre-market price?

As of 2026-09-15 23:48:00, UTHR is trading at $ 502.76 in pre-market trading, up 0.01% ($0.06) from the previous close of $ 502.70. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is UTHR after-hours price?

As of 2026-09-15 23:48:00, UTHR is trading at $ 500.00 in after-hours trading, down 0.54% ($2.70) from the regular-session close of $ 502.70. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is UTHR stock trading now?

UTHR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does UTHR sit relative to its 52-week high and low?

Over the past 52 weeks, UTHR has traded between a low of $ 397.00 and a high of $ 609.35. At $ 500.34, the stock is positioned 48.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is United Therapeutics Corp. in?

United Therapeutics Corp. (UTHR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is United Therapeutics Corp.'s market capitalisation and where is it listed?

United Therapeutics Corp. is listed on the NASDAQ exchange with a market capitalisation of $ 21.56B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is UTHR valued in terms of P/E ratio and EPS?

UTHR trades at a P/E ratio of 16.37, based on trailing-twelve-month EPS of $ 30.56. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does United Therapeutics Corp. pay a dividend?

United Therapeutics Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.